FDA clears United Therapeutics and eGenesis for gene-edited pig kidney transplant studies, including the first clinical trial ...

While 118 biologics are expected to lose patent protection in the US over the next decade, that $234 billion opportunity for ...

Noom lays off coaching and customer service staff after slower-than-expected growth in prescription weight loss drug program.

Fresh off a reorganization, Biogen’s research leader Jane Grogan says the biotech has to 'look outside the walls of the ...

Phar­ma­ceu­ti­cal in­dus­try groups cau­tion that Pres­i­dent Don­ald Trump’s tar­iffs on Chi­na, Mex­i­co and Cana­da will ...

Charles River Laboratories is permanently closing its pathology facility in Durham, NC, after determining it is no longer “a ...

For the first time, the FDA will consider whether to approve a trio of drugs for tiny patient populations based on trials ...

Sen­ate Fi­nance Com­mit­tee De­moc­rats are call­ing Robert F. Kennedy Jr.’s new di­vest­ment plans to his son “plain­ly ...

Thermo Fisher Scientific is cutting 300 employees across two viral vector manufacturing facilities in Massachusetts, marking ...

Cystic fibrosis drug developer Sionna Therapeutics hopes to join the IPO wave started by Metsera and Maze Therapeutics last ...

Tectonic plans $185M private placement after stock swings. Acelyrin returns drug to Affibody. Immunome, 89bio complete offerings. Valneva gets $32.8M DoD contract for Ixiaro vaccine.

Algiax Pharmaceuticals’ non-opioid candidate has achieved “clinically meaningful” pain reduction in a mid-stage trial of ...